Skip to main content
SpringerLink
Log in

Methoden und Ergebnisse toxikologischer Prüfungen von nichtionischen Röntgenkontrastmitteln

  • Conference paper
Röntgenkontrastmittel

Zusammenfassung

Die Ergebnisse aus den toxikologischen Untersuchungen am Tier sind die essentielle Grundlage für die Abschätzung des Anwendungsrisikos von neuen Röntgenkontrastmitteln (RKM) für den Menschen. Die tierexperimentellen toxikologischen Untersuchungen sollen dazu dienen, das Nebenwirkungsspektrum neuer RKM zu beschreiben und die gefundenen Ergebnisse mit denjenigen bereits bekannter Präparate zu vergleichen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatur

  1. Ahlgren P (1973) Long term side effects after myelography with watersoluble contrast media: Conturex, Conray Meglumin 282 and Dimer-X. Neuroradiology 6: 206–211

    Article  PubMed  CAS  Google Scholar 

  2. Ahlgren P (1975) Amipaque myelography. The side effects compared with Dimer X. Neuroradiology 9: 197–202

    Article  PubMed  CAS  Google Scholar 

  3. Ahlgren P (1980) Early and late side effects of water-soluble contrast media for myelography and cisternography: A short review. Invest Radiol 15 [Suppl]: 264–266

    Article  Google Scholar 

  4. Battenfeld R (1980) Licht- und elektronenmikroskopische Untersuchungen der osmotischen Nephrose nach Applikation eines Röntgenkontrastmittels. Dissertation, Tierärztliche Hochschule Hannover

    Google Scholar 

  5. Bhargava AS et al. (in print) The effect of single i. v. application of three non-ionic contrast media in experimental animals with regard to renal changes (interspecies comparison between rats and rabbits)

    Google Scholar 

  6. Cigarroa RG et al. (1989) Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86: 649–652

    Article  PubMed  CAS  Google Scholar 

  7. Cronovist S (1977) Examination of the subarachnoid space with a water soluble contrast medium (Amipaque). J Neuroradiol 4: 13–27

    Google Scholar 

  8. Ennis M et al. (1989) Histamine release from canine lung and liver mast cells induced by radiographic contrast media. Agents Actions 27: 101–103

    Article  PubMed  CAS  Google Scholar 

  9. Graser C et al. (1979) Zur Myelographie mit Metrizamid. Dtsch Med Wochenschr 104: 511–514

    Article  PubMed  CAS  Google Scholar 

  10. Günzel P (1984) Schließen vom präklinischen Experiment auf den Menschen. In: Kuemmerle HP et al. (eds) Klinische Pharmakologie, Bd 1, II-2.4.8, 4. Aufl., ecomed, Landsberg, S 1–5

    Google Scholar 

  11. Günzel P (1984) Grundsätzliche Überlegungen zur Durchführung experimenteller toxikologischer Untersuchungen. In: Kuemmerle H-P et al. (eds) Klinische Pharmakologie, Bd 1, II-2.4.1, 4. Aufl., ecomed, Landsberg, S 1–7

    Google Scholar 

  12. Günzel P, Schöbel Ch (1984) Systemische Verträglichkeitsprüfung bei einmaliger Verabreichung — akute Toxizitätsprüfung. In: Kuemmerle H-P et al. (eds) Klinische Pharmakologie, Bd 1, II-2.4.2, 4. Aufl. ecomed, Landsberg, S 1–4

    Google Scholar 

  13. Günzel P et al. (1986) Zur toxikologischen Prüfung von Kontrastmitteln. In: Burger OK et al. (Hrsg) Aktuelle Probleme der Biomedizin, de Gruyter, Berlin New York, S 275–288

    Google Scholar 

  14. Günzel P (in print) Toxikologie von Pharmazeutika, Besondere Verträglichkeitsprüfungen, Diagnostika (Röntgen- u. a. Kontrastmittel). In: Arbeitstechniken der Pharmazeutischen Industrie, Bd 6, Thieme, Stuttgart

    Google Scholar 

  15. Hansen EB et al. (1978) Late meningeal effects of myelographic contrast media with special reference to metrizamide. Br J Radiol 51: 321–327

    Article  PubMed  CAS  Google Scholar 

  16. Haughton VM et al. (1977) Arachnoiditis following myelography with metrizamide in monkeys. Effect of blood in the cerebrospinal fluid. Acta Radiol Suppl 355: 373–378

    PubMed  CAS  Google Scholar 

  17. Haughton VM et al. (1977) Experimental production of arachnoiditis with water-soluble myelographic media. Radiology 123: 681–685

    PubMed  CAS  Google Scholar 

  18. Haughton VM et al. (1977) Arachnoiditis following myelography with water-soluble agents. Radiology 125: 731–733

    PubMed  CAS  Google Scholar 

  19. Haughton VM et al. (1978) Comparison of arachnoiditis produced by meglumine locar-mate and metrizamide myelography in an animal model. Am J Roentgenol 131: 129–132

    CAS  Google Scholar 

  20. Haughton VM, Ho KC (1980) The risk of arachnoiditis from experimental nonionic contrast media. Radiology 136: 395–397

    PubMed  CAS  Google Scholar 

  21. Haughton VM, Ho KC (1980) Arachnoid response to contrast media: a comparison of iophendylate and metrizamide in experimental animals. Radiology 143: 699–702

    Google Scholar 

  22. Haughton VM et al. (1982) Experimental study of arachnoidits from iohexol, an investigational nonionic aqueous contrast medium. Am J Neuroradiol 3: 375–377

    PubMed  CAS  Google Scholar 

  23. Haughton VM, Ho KC (1982) Effect of blood on arachnoiditis from aqueous myelographic contrast media. Am J Roentgenol 139: 569–570

    CAS  Google Scholar 

  24. Haughton VM (1985) Intrathecal toxicity of iohexol vs metrizamide. Survey and current state. Invest Radiol 20 [Suppl 1]: S14–S17

    Article  PubMed  CAS  Google Scholar 

  25. Irstam L, Rosencrantz M (1974) Water-soluble contrast media and adhesive arachnoiditis. Acta Radiol 15: 1–15

    CAS  Google Scholar 

  26. Irstam L (1978) Lumbar myelography with amipaque. Spine 3: 70–82

    Article  PubMed  CAS  Google Scholar 

  27. Irstam L et al. (1974) Lumbar myelography and adhesive arachnoiditis. Acta Radiol Diagn 15: 356–368

    CAS  Google Scholar 

  28. Johansen JG et al. (1984) Arachnoiditis from myelography and laminectomy in experimental animals. Am J Neuroradiol 5: 97–99

    PubMed  CAS  Google Scholar 

  29. Jorgensen J et al. (1975) A clinical and radiological study of chronic lower spinal arachnoiditis. Neuroradiol 9: 139–144

    Article  CAS  Google Scholar 

  30. Kröpelin T et al. (1983) The risk liability of nephrotropic contrast media: clinical and experimental results. In: Taenzer V, Ziller E (eds) Contrast media in urography, angiography and computerized tomography. Thieme, Stuttgart New York, pp 129–142

    Google Scholar 

  31. Lang JH et al. (1976) Activation of serum complement by contrast media. Invest Radiol 11: 303–308

    Article  PubMed  CAS  Google Scholar 

  32. Lang R (1984) Prüfung auf genotoxische Wirkung. In: Kuemmerle HP et al. (eds) Klinische Pharmakologie, Bd 1, II-2.4.5, 4. Aufl. ecomed, Landsberg, S 1–6

    Google Scholar 

  33. Liliequist B, Lundström B (1974) Lumbar myelography and arachnoiditis. Neuroradiol 7: 91–94

    Article  CAS  Google Scholar 

  34. McCormick CC et al. (1981) Myelography with metrizamide. An analysis of the complications encountered in cervical, thoracic and lumbar myelography. Aust NZ J Med 11: 645–650

    Article  CAS  Google Scholar 

  35. McNeill TW et al. (1976) A new advance in water-soluble myelography. Spine 1:72–84

    Article  Google Scholar 

  36. Moreau JF et al. (1980) Tubular nephrotoxicity of water-soluble iodinated contrast media. Invest Radiol 15 [Suppl 6]: S54–S60

    Article  PubMed  CAS  Google Scholar 

  37. Muetzel W, Speck U (1983) Tolerance and biochemical pharmacology of iopromide. In: Taenzer V, Zeitler E (eds) Contrast media in urography, angiography and computerized tomography. Thieme, Stuttgart New York, pp 11–17

    Google Scholar 

  38. Muetzel W, Speck U (1983) Tolerance and biochemical pharmacology of iopromide. ROFO 118: 11–17

    Google Scholar 

  39. Muetzel W, Speck U (1983) Pharmacochemical profile of iopromide. Am J Neuroradiol 4: 350–352

    PubMed  CAS  Google Scholar 

  40. Pacsaoglu A et al. (1988) An experimental evaluation of response to contrast media. Pantopaque, iopamidol, and iohexol in the subarachnoid space. Invest Radiol 23: 762–766

    Article  Google Scholar 

  41. Poggel H-A (1984) Reproduktionstoxikologische Untersuchungen. In: Kuemmerle HP et al. (eds) Klinische Pharmakologie, Bd 1, II-2.4.6, 4. Aufl. ecomed, Landsberg, S 1–10

    Google Scholar 

  42. Press WR et al. (1989) Tolerance to iotrolan after subarachnoid injection in animals. ROFO 128: 126–133

    CAS  Google Scholar 

  43. Schöbel Ch, Günzel P (1984) Systemische Verträglichkeitsprüfungen bei wiederholter Verabreichung — subakute und chronische Toxizitätsprüfung. In: Kuemmerle HP et al. (eds) Klinische Pharmakologie, Bd 1 II-2.4.3, 4. Aufl. ecomed, Landsberg, S 1–7

    Google Scholar 

  44. Schöbel Ch, Siegmund F (1984) Lokale Verträglichkeitsprüfungen. In: Kuemmerle HP et al. (eds) Klinische Pharmakologie, Bd 1 II-2.4.7, 4. Aufl. ecomed, Landsberg, S 1–7

    Google Scholar 

  45. Schmidt RC (1980) Mental disorders after myelography with metrizamide and other water-soluble contrast media. Neuroradiology 19: 153–157

    Article  PubMed  CAS  Google Scholar 

  46. Skalpe IO (1978) Adhesive arachnoiditis following lumbar myelography. Spine 3: 61–64

    Article  PubMed  CAS  Google Scholar 

  47. Skalpe IO (1977) Lumbale Myelographie mit wasserlöslichen Kontrastmitteln (Metriz-amid). Akt Neurol 4: 179–183

    Google Scholar 

  48. Slätis P et al. (1974) Hyperosmolality of the cerebrospinal fluid as a cause of adhesive arachnoiditis in lumbar myelography. Acta Radiol Diagn 15: 619–629

    Google Scholar 

  49. Tirone P, Boldrini E (1983) Effects of radiographic contrast media on the serum complement system. Arch Toxicol [Suppl 6]: 37–41

    Google Scholar 

  50. Allgemeine Verwaltungsvorschrift zur Anwendung der Arzneimittelprüfrichtlinien vom 14. Dezember 1989. Bundesanzeiger 41 (243a)

    Google Scholar 

  51. Commission of the European Communities, Directorate-General for internal market and industrial affairs, Brussels. 11/BG. 11/118/87-EN, Rev 11, Jan 1988 — Final, Notice to applicants for marketing authorizations for proprietary medicinal products in the member states of the European community

    Google Scholar 

Download references

Authors
  1. Ch. Schöbel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Günzel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Klinische Radiologie, Westfälische Wilhelms-Universität, Albert-Schweitzer-Straße 33, W-4400, Münster, Bundesrepublik Deutschland

    P. E. Peters

  2. Radiologisches Zentrum, Klinikum Nürnberg, Flurstraße 17, W-8500, Nürnberg, Bundesrepublik Deutschland

    E. Zeitler

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schöbel, C., Günzel, P. (1991). Methoden und Ergebnisse toxikologischer Prüfungen von nichtionischen Röntgenkontrastmitteln. In: Peters, P.E., Zeitler, E. (eds) Röntgenkontrastmittel. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76338-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76338-0_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-53550-8

  • Online ISBN: 978-3-642-76338-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation